Secant Medical’s research in biomaterials and advanced textile structures
Ryan Heniford, Business Development Director at Secant Medical, will present during Techtextil North America 2014. His presentation will highlight Secant Medical’s research and development in biomaterials and advanced textile structures for regenerative medicine applications. The exhibit and symposium will be at the Georgia World Congress Center in Atlanta, May 13–15.
Heniford will be speaking during the session titled “Medical: Research and Application Based” on May 14 between 8:30 am and 11:00 am. His presentation, “Textiles and Regenerative Medicine”, will provide an overview of the potential uses of biomedical structures in regenerative applications. He will also highlight the considerations necessary for developing fibers and fabrics for regenerating the human body.
“The symposium will highlight novel materials and innovative textile structures that are being developed to meet the challenges of the medical device industry,” said Heniford. “I look forward to sharing our work surrounding textiles and biomaterials development to advance future structures for regenerative medicine in a variety of in vivo applications for cardiovascular, orthopedics, neurovascular and tissue engineering.”
About Techtextil North America: North America’s only dedicated show for technical textiles and nonwovens. Techtextil North America assembles all vertical aspects of the technical textile industry. From research and development, through raw materials and production processes and finally ending in conversion, further treatment and recycling. The show includes an exhibit hall and a symposium, which will address market developments, technological information, new technical processes and products, as well as international industry trends.
About Secant Medical: Secant Medical provides advanced biomaterials and biomedical textile structures to the medical device industry. We partner with clients to design, develop, and manufacture high-performance biomedical structures for applications in cardiovascular, neurovascular, orthopedic and general surgery.
Built on a 70-year history, we’re committed to the future of regenerative medicine and actively engage in research partnerships to advance next-generation biomaterial technology into practical applications for the medical device and pharmaceutical industries.